Ströer SE & Co. KGaA Logo

Ströer SE & Co. KGaA

A media company providing integrated out-of-home (OOH) and digital advertising solutions.

SAX | F

Overview

Corporate Details

ISIN(s):
DE0007493991 (+1 more)
LEI:
529900MBF3N1ATE55378
Country:
Germany
Address:
Ströer Allee 1, 50999 Köln
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ströer SE & Co. KGaA is a leading German media company specializing in out-of-home (OOH) advertising, complemented by digital advertising and dialogue marketing. The company provides advertisers with customized, fully integrated marketing solutions through its "OOH plus" strategy, leveraging an extensive portfolio of physical and digital advertising assets, including billboards and street furniture. Ströer's services encompass the entire marketing and sales cycle, offering cross-media campaigns that combine outdoor and online channels. The company also partners with municipalities to integrate its media infrastructure into urban environments, providing public information and cultural services.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-26 09:52
Director's Dealing
Stroer SE & Co. KGaA: Raquel Falomir, buy
English 6.3 KB
2025-09-18 19:36
Earnings Release
Stroer adjusts outlook for financial year 2025
English 6.8 KB
2025-08-13 00:00
Investor Presentation
Presentation on the Half-year financial report 6M/Q2 2025
English 3.1 MB
2025-08-13 00:00
Interim Report
Half-yearly financial report 2025
English 532.1 KB
2025-08-06 13:14
Report Publication Announcement
English 4.0 KB
2025-07-15 17:48
Major Shareholding Notification
English 14.3 KB
2025-05-08 00:00
Investor Presentation
Presentation on the Q1 2025 Statement
English 4.5 MB
2025-04-24 15:05
Pre-Annual General Meeting Information
Stroer SE & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 04…
German 91.4 KB
2025-03-24 00:00
Annual Report
Annual financial report 2024
English 2.8 MB
2025-03-13 00:00
Governance Information
Corporate Governance Declaration (03/13/2025)
English 176.0 KB
2025-03-07 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-06 17:15
Report Publication Announcement
English 4.7 KB
2025-03-06 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-05 17:15
Report Publication Announcement
English 4.7 KB
2025-01-27 00:00
Registration Form
Articles of Association
English 224.6 KB

Automate Your Workflow. Get a real-time feed of all Ströer SE & Co. KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ströer SE & Co. KGaA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ströer SE & Co. KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-06-17 Müller, Udo Board Other None 5,494,929.49 EUR
2022-06-17 Müller, Udo Board Other None 5,245,394.64 EUR
2022-04-12 Patrick, Elizabeth Other Other None N/A
2022-04-08 Müller, Udo Board Other None 2,482,000.00 EUR
2022-04-08 Müller, Udo Board Other None 1,677,015.00 EUR
2022-04-08 Müller, Udo Board Other None 1,510,600.00 EUR
2022-04-08 Müller, Udo Board Other None 2,221,000.00 EUR
2021-12-02 Müller, Udo Board Other None 206,665.84 EUR
2021-12-02 Müller, Udo Board Other None 1,224,161.77 EUR
2021-12-02 Müller, Udo Board Other None 1,224,995.10 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.